Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 075423

Expand all

CLONAZEPAM (CLONAZEPAM)
0.5MG
Marketing Status: Discontinued

Active Ingredient: CLONAZEPAM
Proprietary Name: CLONAZEPAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075423
Product Number: 001
Approval Date: Apr 27, 2001
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CLONAZEPAM (CLONAZEPAM)
1MG
Marketing Status: Discontinued

Active Ingredient: CLONAZEPAM
Proprietary Name: CLONAZEPAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075423
Product Number: 002
Approval Date: Apr 27, 2001
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

CLONAZEPAM (CLONAZEPAM)
2MG
Marketing Status: Discontinued

Active Ingredient: CLONAZEPAM
Proprietary Name: CLONAZEPAM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A075423
Product Number: 003
Approval Date: Apr 27, 2001
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES INC
Marketing Status:  Discontinued
Patent and Exclusivity Information